Collectively, these results demonstrate that YBX1 upregulates CBX3, which consequently represses SMURF2 and activates the TGF-β signaling pathway and promotes malignant progression in pancreatic cancer (Fig. 6J). Here, TGFB1 is linked to pancreatic neoplasm.